Seed round raised from existing investors (True Ventures, BKR Capital, Centre for Aging and Brain Health Innovation, Health2047 and others) – $4.5M to date. Securing of MassAITC pilot funding helped in due diligence with investors for their seed round, and thus was critical to closing their funding including with Health2047, venture arm of the American Medical Association and with other early stage investors.
